Current Edition


With spotlight on FDA, Congress weighs reforms to accelerated drug approvals

Over the past few years, the Food and Drug Administration has come increasingly under scrutiny for its program to grant speedy approvals to drugs that …

Continue Reading →

The pipeline of new antibiotics is drying up. A bill in Congress aims to change that

Bacteria that can defeat current antibiotic drugs are sometimes called “the next pandemic.” Already, infections from them are believed to cause or contribute to more …

Continue Reading →

As Congress weighs drug price restraints, ICER calls out ‘unsupported’ increases

Congress is considering legislation that could force drugmakers to pay steep rebates to Medicare for patent-protected drugs that have price increases exceeding inflation, as well …

Continue Reading →